NASDAQ:AZTA

Azenta (AZTA) Stock Forecast, Price & News

$50.19

+0.62 (+1.25%)

(As of 09/29/2023 ET)

Compare

Today's Range: $49.91
▼
$50.62
50-Day Range: $46.12
▼
$57.76
52-Week Range: $36.01
▼
$63.60

Volume: 1.28 million shs
Average Volume: 856,162 shs
Market Capitalization: $3.02 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $64.50

Azenta MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.60 Rating Score
Upside/Downside: 28.5% Upside
$64.50 Price Target
Short Interest: Bearish
10.29% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.49
Based on 10 Articles This Week
Insider Trading: Selling Shares
$246,762 Sold Last Quarter
Proj. Earnings Growth: 123.08%
From $0.13 to $0.29 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.23 out of 5 stars

Medical Sector

379th out of 972 stocks

Special Industry Machinery, Not Elsewhere Classified Industry

7th out of 15 stocks

3.3

Analyst's Opinion

Consensus Rating
Azenta has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $64.50, Azenta has a forecasted upside of 28.5% from its current price of $50.19.
Amount of Analyst Coverage
Azenta has only been the subject of 3 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
10.29% of the float of Azenta has been sold short.
Short Interest Ratio / Days to Cover
Azenta has a short interest ratio ("days to cover") of 6.7.
Change versus previous month
Short interest in Azenta has recently decreased by 2.57%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Azenta does not currently pay a dividend.
Dividend Growth
Azenta does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AZTA.

1.9

News and Social Media Coverage

News Sentiment
Azenta has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 10 news articles for Azenta this week, compared to 3 articles on an average week.
Search Interest
Only 1 people have searched for AZTA on MarketBeat in the last 30 days. This is a decrease of -83% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Azenta to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Azenta insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $246,762.00 in company stock.
Percentage Held by Insiders
Only 1.67% of the stock of Azenta is held by insiders.
Percentage Held by Institutions
99.08% of the stock of Azenta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Azenta are expected to grow by 123.08% in the coming year, from $0.13 to $0.29 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Azenta is -96.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Azenta is -96.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Azenta has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Azenta (NASDAQ:AZTA) Stock

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

AZTA Price History

30 days | 90 days | 365 days | Advanced Chart

AZTA Stock News Headlines

September 30, 2023 | msn.com

Activist Politan Capital engages with Azenta. Here’s how the firm may boost shareholder value

September 26, 2023 | seekingalpha.com

Azenta appointed Herman Cueto as new CFO as Robertson retires

October 1, 2023 | Behind the Markets (Ad)

[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"

The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. Get the name of the stock here >>>

September 26, 2023 | finance.yahoo.com

Azenta Announces CFO Transition

September 25, 2023 | americanbankingnews.com

Brokerages Set Azenta, Inc. (NASDAQ:AZTA) Target Price at $64.50

September 8, 2023 | finance.yahoo.com

Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

September 7, 2023 | finance.yahoo.com

Azenta to Participate in the Baird 2023 Global Healthcare Conference

September 5, 2023 | finance.yahoo.com

Estimating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA)

October 1, 2023 | Behind the Markets (Ad)

[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"

August 18, 2023 | thestreet.com

Azenta Inc.

August 15, 2023 | msn.com

Azenta ticks higher amid 13F filing from activist Politan Capital

August 10, 2023 | benzinga.com

Azenta Director Trades $1.05M In Company Stock

August 10, 2023 | finance.yahoo.com

Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023

August 10, 2023 | seekingalpha.com

Azenta, Inc. 2023 Q3 - Results - Earnings Call Presentation

August 9, 2023 | msn.com

Why did Azenta stock go up today? Q3 beat

August 9, 2023 | finance.yahoo.com

Azenta to Participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1X1 Conference

August 9, 2023 | finance.yahoo.com

Azenta Reports Results of Third Quarter of Fiscal 2023, Ended June 30, 2023

August 9, 2023 | finance.yahoo.com

Azenta (NASDAQ:AZTA) lifts 4.0% this week, taking five-year gains to 70%

August 8, 2023 | msn.com

Azenta (AZTA) Beats Q3 Earnings and Revenue Estimates

August 8, 2023 | benzinga.com

Azenta Earnings Preview

August 3, 2023 | finance.yahoo.com

Azenta Announces Fiscal 2023 Third Quarter Earnings Conference Call and Webcast

July 27, 2023 | seekingalpha.com

Azenta: Delivering Solid Growth In Life Sciences

July 24, 2023 | finance.yahoo.com

Is Now An Opportune Moment To Examine Azenta, Inc. (NASDAQ:AZTA)?

July 12, 2023 | benzinga.com

Watching Azenta Shares; Traders Circulate Activist Insight Rumor Co Said To Attract Activist Investor

June 29, 2023 | fool.com

Azenta (NASDAQ: AZTA)

June 29, 2023 | finance.yahoo.com

Azenta Announces New Biorepository in the Greater Boston Area

June 22, 2023 | finance.yahoo.com

Here’s Why Polen Capital Global SMID Company Growth Strategy Sold Azenta (AZTA)

See More Headlines

Receive AZTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter.

AZTA Company Calendar

Last Earnings: 8/08/2023
Today: 10/01/2023
Next Earnings (Estimated): 11/13/2023
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Special industry machinery, not elsewhere classified
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:AZTA
CUSIP: N/A
CIK: 933974
Web: www.brooks.com
Phone: (978) 262-2400
Fax: 978-262-2500
Employees: 3,100
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $64.50
High Stock Price Forecast: $70.00
Low Stock Price Forecast: $55.00
Forecasted Upside/Downside: +28.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.60
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.52)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 386.08
P/E Growth: N/A
Net Income: $2.13 billion
Net Margins: -6.09%
Pretax Margin: -4.47%
Return on Equity: 0.84%
Return on Assets: 0.75%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 7.42
Quick Ratio: 6.72

Sales & Book Value

Annual Sales: $555.50 million
Price / Sales: 5.44
Cash Flow: $1.20 per share
Price / Cash Flow: 41.83
Book Value: $44.83 per share
Price / Book: 1.12

Miscellaneous

Outstanding Shares: 60,200,000
Free Float: 59,195,000
Market Cap: $3.02 billion
Optionable: Optionable
Beta: 1.50

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Dr. Stephen S. Schwartz (Age 64)
CEO, Pres & Director
Comp: $1.17M

Mr. Lindon G. Robertson (Age 61)
Exec. VP & CFO
Comp: $1M

Mr. Jason W. Joseph (Age 52)
Sr. VP, Gen. Counsel & Corp. Sec.
Comp: $651.75k

Ms. Vandana Sriram CPA (Age 49)
Corp. Controller
Comp: $800.2k

Mr. Robin Vacha (Age 47)
Sr. VP of Global Operations

Violetta Hughes
VP & Chief Accounting Officer

Mr. Michael Paulo
VP and Chief Information & Digital Officer

Sara Silverman
Head of Investor Relations & Corp. Communications

Mr. John E. O'Brien (Age 53)
Sr. VP of Corp. Devel.

Dr. Claribel Purcell
Sr. VP of Global Sales

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

AZTA Stock - Frequently Asked Questions

Should I buy or sell Azenta stock right now?: 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Azenta in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" AZTA shares.
View AZTA analyst ratings or view top-rated stocks.
What is Azenta's stock price forecast for 2023?: 5 brokers have issued 12 month price objectives for Azenta's stock. Their AZTA share price forecasts range from $55.00 to $70.00. On average, they anticipate the company's share price to reach $64.50 in the next twelve months. This suggests a possible upside of 28.5% from the stock's current price.
View analysts price targets for AZTA or view top-rated stocks among Wall Street analysts.
How have AZTA shares performed in 2023?: Azenta's stock was trading at $58.22 on January 1st, 2023. Since then, AZTA stock has decreased by 13.8% and is now trading at $50.19.
View the best growth stocks for 2023 here.
When is Azenta's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our AZTA earnings forecast.
How were Azenta's earnings last quarter?: Azenta, Inc. (NASDAQ:AZTA) issued its quarterly earnings data on Tuesday, August, 8th. The company reported $0.13 EPS for the quarter, topping analysts' consensus estimates of ($0.03) by $0.16. The company earned $165.95 million during the quarter, compared to the consensus estimate of $153.42 million. Azenta had a negative net margin of 6.09% and a positive trailing twelve-month return on equity of 0.84%. The company's quarterly revenue was up 25.0% compared to the same quarter last year. During the same period last year, the firm posted $0.12 EPS.
What ETFs hold Azenta's stock?: ETFs with the largest weight of Azenta (NASDAQ:AZTA) stock in their portfolio include ROBO Global Healthcare Technology and Innovation ETF (HTEC), ROBO Global Robotics & Automation ETF (ROBO), Harbor Health Care ETF (MEDI) and Principal Healthcare Innovators ETF (BTEC).BlackRock Future Innovators ETF (BFTR).

What guidance has Azenta issued on next quarter's earnings?: Azenta updated its fourth quarter 2023 earnings guidance on Wednesday, September, 27th. The company provided earnings per share (EPS) guidance of -$0.02-$0.06 for the period, compared to the consensus estimate of $0.02. The company issued revenue guidance of $155.00 million-$173.00 million, compared to the consensus revenue estimate of $163.74 million.
What is Azenta's stock symbol?: Azenta trades on the NASDAQ under the ticker symbol "AZTA."
How do I buy shares of Azenta?: Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Azenta's stock price today?: One share of AZTA stock can currently be purchased for approximately $50.19.
How much money does Azenta make?: Azenta (NASDAQ:AZTA) has a market capitalization of $3.02 billion and generates $555.50 million in revenue each year. The company earns $2.13 billion in net income (profit) each year or ($0.52) on an earnings per share basis.
How many employees does Azenta have?: The company employs 3,100 workers across the globe.
How can I contact Azenta?: Azenta's mailing address is 15 Elizabeth Dr, Chelmsford, Massachusetts 01824-4111. The official website for the company is www.brooks.com. The company can be reached via phone at (978) 262-2400, via email at investor@brooks.com, or via fax at 978-262-2500.

This page (NASDAQ:AZTA) was last updated on 10/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Azenta (AZTA) Stock Forecast, Price & News

Azenta MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Azenta (NASDAQ:AZTA) Stock

AZTA Price History

AZTA Stock News Headlines

AZTA Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

AZTA Stock - Frequently Asked Questions

Overall MarketRank^™